CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel

Vicki Plaks; John M. Rossi; Justin Chou; Linghua Wang; Soumya Poddar; Guangchun Han; Zixing Wang; Shao Qing Kuang; Fuliang Chu; Richard E. Davis; Francisco Vega; Zahid Bashir; Caron A. Jacobson; Frederick L. Locke; Patrick M. Reagan; Scott J. Rodig; Lazaros J. Lekakis; Ian W. Flinn; David B. Miklos; Adrian Bot; Sattva S. Neelapu

doi:10.1182/blood.2021010930

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel

Vicki Plaks, John M. Rossi, Justin Chou, Linghua Wang, Soumya Poddar, Guangchun Han, Zixing Wang, Shao Qing Kuang, Fuliang Chu, Richard E. Davis, Francisco Vega, Zahid Bashir, Caron A. Jacobson, Frederick L. Locke, Patrick M. Reagan, Scott J. Rodig, Lazaros J. Lekakis, Ian W. Flinn, David B. Miklos, Adrian BotSattva S. Neelapu

Research output: Contribution to journal › Letter › peer-review

76 Scopus citations

Original language	English (US)
Pages (from-to)	1081-1085
Number of pages	5
Journal	Blood
Volume	138
Issue number	12
DOIs	https://doi.org/10.1182/blood.2021010930
State	Published - Sep 23 2021

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2021010930

Cite this

Plaks, V., Rossi, J. M., Chou, J., Wang, L., Poddar, S., Han, G., Wang, Z., Kuang, S. Q., Chu, F., Davis, R. E., Vega, F., Bashir, Z., Jacobson, C. A., Locke, F. L., Reagan, P. M., Rodig, S. J., Lekakis, L. J., Flinn, I. W., Miklos, D. B., ... Neelapu, S. S. (2021). CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel. Blood, 138(12), 1081-1085. https://doi.org/10.1182/blood.2021010930

Plaks, V, Rossi, JM, Chou, J, Wang, L, Poddar, S, Han, G, Wang, Z, Kuang, SQ , Chu, F , Davis, RE , Vega, F, Bashir, Z, Jacobson, CA, Locke, FL, Reagan, PM, Rodig, SJ, Lekakis, LJ, Flinn, IW, Miklos, DB, Bot, A & Neelapu, SS 2021, 'CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel', Blood, vol. 138, no. 12, pp. 1081-1085. https://doi.org/10.1182/blood.2021010930

@article{df50ea9d76d54898b00ab420bd4d00ad,

title = "CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel",

author = "Vicki Plaks and Rossi, {John M.} and Justin Chou and Linghua Wang and Soumya Poddar and Guangchun Han and Zixing Wang and Kuang, {Shao Qing} and Fuliang Chu and Davis, {Richard E.} and Francisco Vega and Zahid Bashir and Jacobson, {Caron A.} and Locke, {Frederick L.} and Reagan, {Patrick M.} and Rodig, {Scott J.} and Lekakis, {Lazaros J.} and Flinn, {Ian W.} and Miklos, {David B.} and Adrian Bot and Neelapu, {Sattva S.}",

note = "Funding Information: This work was partly supported by the University of Texas MD Anderson Cancer Center B-cell Lymphoma Moonshot (S.S.N.) and National Institutes of Health, National Cancer Institute Cancer Center Support Grant P30 CA016672 to the University of Texas MD Anderson Cancer Center. Funding Information: The authors thank Francesca Milletti, Jenny J. Kim, Shruti Salunkhe, Stuart A. Sievers, Lianqing Zheng, Allen Xue, and Scott Turner for their contributions to this work. Medical writing support was provided by Ashley Skorusa and Skye Geherin of Nexus Global Group Science, funded by Kite, a Gilead Company. ",

year = "2021",

month = sep,

day = "23",

doi = "10.1182/blood.2021010930",

language = "English (US)",

volume = "138",

pages = "1081--1085",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "12",

}

TY - JOUR

T1 - CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel

AU - Plaks, Vicki

AU - Rossi, John M.

AU - Chou, Justin

AU - Wang, Linghua

AU - Poddar, Soumya

AU - Han, Guangchun

AU - Wang, Zixing

AU - Kuang, Shao Qing

AU - Chu, Fuliang

AU - Davis, Richard E.

AU - Vega, Francisco

AU - Bashir, Zahid

AU - Jacobson, Caron A.

AU - Locke, Frederick L.

AU - Reagan, Patrick M.

AU - Rodig, Scott J.

AU - Lekakis, Lazaros J.

AU - Flinn, Ian W.

AU - Miklos, David B.

AU - Bot, Adrian

AU - Neelapu, Sattva S.

N1 - Funding Information: This work was partly supported by the University of Texas MD Anderson Cancer Center B-cell Lymphoma Moonshot (S.S.N.) and National Institutes of Health, National Cancer Institute Cancer Center Support Grant P30 CA016672 to the University of Texas MD Anderson Cancer Center. Funding Information: The authors thank Francesca Milletti, Jenny J. Kim, Shruti Salunkhe, Stuart A. Sievers, Lianqing Zheng, Allen Xue, and Scott Turner for their contributions to this work. Medical writing support was provided by Ashley Skorusa and Skye Geherin of Nexus Global Group Science, funded by Kite, a Gilead Company.

PY - 2021/9/23

Y1 - 2021/9/23

UR - http://www.scopus.com/inward/record.url?scp=85113542703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113542703&partnerID=8YFLogxK

U2 - 10.1182/blood.2021010930

DO - 10.1182/blood.2021010930

M3 - Letter

C2 - 34041526

AN - SCOPUS:85113542703

SN - 0006-4971

VL - 138

SP - 1081

EP - 1085

JO - Blood

JF - Blood

IS - 12

ER -

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this